Concept
Depression Treatment
8 studies
Depression treatment evidence covers pharmacological, psychological, and digital interventions aimed at reducing depressive symptoms.
Mental-health care is outcome-driven; symptom scales and trial arms show what moves scores.
Studies
8
Findings
6
8 supporting · 0 challenging · 0 qualifying citations
Open tensions
1
Currently
What we know
- Multiple studies in this library examine depression treatment with empirical patient or population outcomes rather than opinion alone.
- Immediate treatment improved ~5.4 BDI points (d=0.58) with a significant condition×time interaction; delayed group showed essentially no BDI change over the same interval.
- Low-to-moderate intake (>5–15 g/day) had HR 0.72 (95% CI 0.53–0.98); wine dominated alcohol intake (82% of variability); heavy drinkers appeared at higher risk.
- CDI rates were 282.9 vs 197.1 per 100,000 person-years with vs without depression; adjusted odds of CDI were 36% higher with major depression; widowhood and living alone also associated.
- iCBT produced moderate between-group benefits on PHQ-9 (Hedges g=0.78) and GAD-7 (g=0.72), plus large effects on diabetes distress and general distress. About 66% completed all six lessons; 51% of iCBT completers with data showed reliable PHQ-9 improvement vs 18% of TAU.
Largest unresolved question
Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Common misconceptions
Depression Treatment findings always generalise to every clinic.
These studies are context-bound; designs, populations, and endpoints limit transfer.
Related
Claim ledger
What the evidence shows
Drawn from 8 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
Multiple studies in this library examine depression treatment with empirical patient or population outcomes rather than opinion alone.
- Deprexis online therapy reduced depression scores
- Wine, alcohol, and depression
- Depression linked to C. difficile infection risk
Study Role Design N Population Outcome Deprexis online therapy reduced depression scores Supports RCTImmediate Deprexis vs delayed treatment; online recruitment N=396 · 81% assigned to immediate treatment Adults with depression symptoms recruited online for Deprexis BDI change over time (condition × time) Wine, alcohol, and depression Supports CohortObservational analysis within PREDIMED participants N=5505 · Older Mediterranean adults; 443 incident depression cases Older adults in the PREDIMED Mediterranean cohort Incident depression by baseline alcohol/wine intake (Cox HRs) Depression linked to C. difficile infection risk Supports CohortLinked HRS–Medicare analyses plus complementary clinical cohorts N=16781 · HRS–CMS linked Study 1 sample size; complementary clinical cohorts also reported Older US adults in the Health and Retirement Study linked to Medicare claims Clostridium difficile infection rates/odds by depression and antidepressant exposure Immediate treatment improved ~5.4 BDI points (d=0.58) with a significant condition×time interaction; delayed group showed essentially no BDI change over the same interval.
Low-to-moderate intake (>5–15 g/day) had HR 0.72 (95% CI 0.53–0.98); wine dominated alcohol intake (82% of variability); heavy drinkers appeared at higher risk.
CDI rates were 282.9 vs 197.1 per 100,000 person-years with vs without depression; adjusted odds of CDI were 36% higher with major depression; widowhood and living alone also associated.
iCBT produced moderate between-group benefits on PHQ-9 (Hedges g=0.78) and GAD-7 (g=0.72), plus large effects on diabetes distress and general distress. About 66% completed all six lessons; 51% of iCBT completers with data showed reliable PHQ-9 improvement vs 18% of TAU.
224 depression cases (median 5.4 years). Merged MD HR 0.85 (NS). MD-nuts nonsignificantly inverse overall; significant benefit in DM2 subgroup.
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
- Deprexis online therapy reduced depression scores
- Wine, alcohol, and depression
- Depression linked to C. difficile infection risk
Study Role Design N Population Outcome Deprexis online therapy reduced depression scores Supports RCTImmediate Deprexis vs delayed treatment; online recruitment N=396 · 81% assigned to immediate treatment Adults with depression symptoms recruited online for Deprexis BDI change over time (condition × time) Wine, alcohol, and depression Supports CohortObservational analysis within PREDIMED participants N=5505 · Older Mediterranean adults; 443 incident depression cases Older adults in the PREDIMED Mediterranean cohort Incident depression by baseline alcohol/wine intake (Cox HRs) Depression linked to C. difficile infection risk Supports CohortLinked HRS–Medicare analyses plus complementary clinical cohorts N=16781 · HRS–CMS linked Study 1 sample size; complementary clinical cohorts also reported Older US adults in the Health and Retirement Study linked to Medicare claims Clostridium difficile infection rates/odds by depression and antidepressant exposure
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
Depression Treatment
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Coverage edits are distinct from reviewed research changes and corrections. Dates record PaperFren updates; study publication dates appear in the timeline.
- Coverage updated · Concept page published
Papers
8 studies in this library bear on Depression Treatment, ordered by citations.
- Deprexis online therapy reduced depression scores
An integrative online program (Deprexis) improved BDI depression symptoms versus delayed treatment in a large German internet RCT.
- Mediterranean diet and depression risk
Overall Mediterranean diet assignment did not significantly reduce depression; a nuts arm suggested benefit in diabetes subgroup analyses.
- Diet quality and depression risk
In the SUN cohort, higher adherence to Mediterranean, pro-vegetarian, and AHEI-2010 diet scores tracked with lower risk of incident depression over about 8.5 years.
- Can a CBT phone app help stubborn depression?
Adding a smartphone CBT program to a medication switch improved depressive symptoms more than switching antidepressants alone.
- Wine, alcohol, and depression
In PREDIMED adults, low-to-moderate alcohol—especially wine—associated with lower incident depression risk versus abstaining, while heavy drinking looked riskier.
- iCBT for depression in diabetes
Unmodified clinician-supported iCBT beat treatment-as-usual on depression, anxiety, distress, and diabetes-specific distress in adults with diabetes.
- Depression linked to C. difficile infection risk
Adults with major depression had higher CDI rates, and specific antidepressants plus living alone/widowhood also associated with infection risk.
- Antidepressant adverse events cohort
In 238,963 adults aged 20–64 with depression, most used antidepressants and several common agents associated with higher fall rates versus non-use.
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Ask PaperFren about Depression Treatment
Study this conceptflashcards and short-answer questions
What is Depression Treatment and why do health students study it?
Depression treatment evidence covers pharmacological, psychological, and digital interventions aimed at reducing depressive symptoms. Mental-health care is outcome-driven; symptom scales and trial arms show what moves scores.
Name one limit of the evidence base for Depression Treatment in this library.
Single-setting trials, observational designs, or digital-only samples limit causal and external claims.
Flashcards
0 of 1 answers reviewed